Incyte to Present at the Oppenheimer 23rd Annual Healthcare Conference Oppenheimer Healthcare Conference 2012 Business Wire WILMINGTON, Del. -- November 28, 2012 Incyte Corporation (Nasdaq:INCY) announced today it will present at the Oppenheimer 23^rd Annual Healthcare Conference on Thursday, December 13 at 1:35 p.m. (EST) in New York. The presentation will be webcast live and can be accessed at www.incyte.com under Investor Relations, Events and Webcasts. A replay of the presentation will be available for 90 days. Investors interested in listening to the live webcast should log on before the start time in order to download any software required. Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary small molecule drugs for oncology and inflammation. For additional information on Incyte, please visit the Company's web site at www.incyte.com. Contact: Incyte Corporation Pamela M. Murphy Vice President, Investor Relations & Corporate Communications 302-498-6944
Incyte to Present at the Oppenheimer 23rd Annual Healthcare Conference
Press spacebar to pause and continue. Press esc to stop.